Cabaletta Bio, Inc. (BOATS:CABA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Shawn Tomasello Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Kalaris Therapeutics, Inc. (Director · Mar 29, 2022 – Jun 6, 2024 · Past); Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); UroGen Pharma Ltd. (Director · Jun 7, 2021 – Jun 7, 2021 · Past); Tcr2 Therapeutics Inc (Director · Feb 3, 2021 – Jun 1, 2023 · Past) | Director · Since at least Jul 21, 2023 |
| Brian Daniels Other companies: Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Bristol-Myers Squibb Company (SVP Global Dev & Med Affairs · Mar 4, 2008 – Jul 1, 2014 · Past) | Director · Oct 24, 2019 – Jun 1, 2021 · Past |
| Scott Brun Other companies: Jasper Therapeutics, Inc. (Director · Since at least Jun 20, 2023); Forte Biosciences, Inc. (Director · Since at least Nov 10, 2022) | Independent Director, formerly at AbbVie · Since at least Jun 24, 2021 |
| Gwendolyn Binder Other companies: Instil Bio, Inc. (Board Member · Since at least Mar 18, 2021) | President, Science & Technology · Since at least Oct 24, 2019 |
| Richard C Henriques Jr Other companies: Arbutus Biopharma Corporation (Director · Dec 31, 2014 – May 23, 2024 · Past) | Director · Since at least Oct 24, 2019 |
| Anup Marda | Chief Financial Officer · Since at least Oct 24, 2019 |
| Arun Das | Chief Business Officer · Since at least Jan 5, 2022 |
| Catherine Bollard | Independent Director, George Washington University · Since at least Oct 24, 2019 |
| David J. Chang | Chief Medical Officer · Since at least Oct 24, 2019 |
| Heather Harte-Hall | Chief Compliance Officer · Since at least Nov 5, 2026 |
| John Brian Stalter | General Counsel · Oct 24, 2019 – Mar 1, 2021 · Past |
| Mark Simon | Director · Since at least Jun 3, 2024 |
| Michael Gerard | General Counsel · Since at least Sep 1, 2021 |
| Nicolette Sherman | Chief Human Resources Officer · Since at least Nov 14, 2024 |
| Richard Henriques | Independent Director, former CFO of Gates Foundation, former Controller at Merck · Since at least Nov 5, 2026 |
| Samik Basu | Chief Scientific Officer · Since at least Oct 9, 2025 |
| Sarah Yuan | Chief Technology Officer · Since at least Nov 5, 2026 |
| Steve Gavel | Chief Commercial Officer · Since at least Oct 14, 2025 |
| Steven Nichtberger | President, Chief Executive Officer, and Co-Founder · Since at least Aug 13, 2026 |
| Steven Nichtberger | President & CEO, Director · Since at least Oct 24, 2019 |